Awards
2018 CCC Trio Poster Award
2016 Otto-Kraupp habilitation award; Winner in the category „Best written thesis“ (Petra Heffeter)
2016 Förderpreis der Stadt Wien (Publication award)
2014 INiTS award; Winner in the category „Life science“
2014 RIZ Genius award; category “Research”
2011 Forschungsentwicklungspreis des Fonds der Stadt Wien für innovative interdisziplinäre Krebsforschung
Approved International Peer-Reviewed Projects
» Austrian Science Fond (FWF) grant P28853 (Tyrosine kinase inhibitor prodrugs to reduce side effects and resistance development).
» Austrian Science Fond (FWF) grant P26603 (Tumor-targeting of oxaliplatin and cisplatin by an albumin-affine prodrug design).
» Austrian Science Fond (FWF) grant P22072 (New Thiosemicarbazone-Based Anticancer Drugs).
» AWS Prize (Tumor-specific Tyrosinkinase inhibitors for targeted cancer therapy).
» Austrian Research Promotion Agency (FFG) (Bacterial ghosts as carriers for targeted cancer therapy).
» Johanna Mahlke, geb. Obermann-Stiftung (Liposomal drug delivery systems)
» Initiative Krebsforschung (Tumor-specific activation of clinically approved tyrosine kinase inhibitors by cathepsin B).
» Herzfelder´sche Familienstiftung (Impact of targeted therapeutics on the anticancer activity of new metal compounds).
» Research assignment from the Fellinger Krebsforschung (Proteinbiomarker zur Vorhersage der Sensitivität von Tumorzellen gegen die neue Rutheniumverbindung KP1339).
» Research assignment from the Fellinger Krebsforschung (Mechanisms underlying the sensitivity and resistance of cancer cells to KP1339: The role of ER homeostasis, integrins and autophagy).